Consultations
We consult on proposed changes to the way we regulate medicines, medical devices and biologicals. Additional consultations about changes to the Poisons Standard can be found in the Scheduling decisions (interim) section of our publications hub.
See all open and recent consultations, submissions and decisions at the TGA Consultation hub.
More on consultations
Find more scheduling consultations on the Poisons Standard in our Interim decisions.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (74)
- Therapeutic goods regulation (18)
- Over the counter (OTC) medicines (14)
- Prescription medicines (14)
- Legislation (11)
- Complementary medicines (9)
- Non-prescription medicines (9)
- Advisory bodies and committees (8)
- Listed medicines (8)
- Labelling and packaging (6)
- Manufacturing (6)
- Medical devices safety (4)
- Advertising (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Medicines safety (3)
- Sunscreens (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Fees and payments (2)
- Import and export (2)
- Safety (2)
- Shortages (2)
- Artificial Intelligence (AI) (1)
- Clinical trials (1)
- Disinfectants/Sterilants (1)
- Medicinal cannabis hub (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Please use the filters or search function to help find relevant consultations.
Results for
"[search-keyword]"
Search
243 result(s) found, displaying 51 to 75
-
ConsultationPublic consultation on the Product Information (PI) as a package insert in boxed injectable products.
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 29 September 2022
-
ConsultationThe (TGA) is seeking feedback on proposed regulatory changes to strengthen safety oversight of clinical trials for medical devices.
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 15-16th March 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationClosed: 15 September 2022. Consultation results are now available on the TGA Consultation Hub
-
ConsultationThe Therapeutic Goods Administration (TGA) is seeking feedback on whether or not certain international scientific guidelines should be adopted.
-
ConsultationThe Australian Government is undertaking a significant program to reform the regulation of therapeutic goods in Australia. As part of the Australian Government Department of Health, the Therapeutic Goods Administration (TGA) regulates therapeutic goods, and is responsible for implementing the Government’s reforms. The TGA has issued this survey as part of the Government’s reform program.
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 27 May 2022
-
ConsultationThis consultation is for applications and delegate initiated proposals to amend the Poisons Standard. The scheduling amendments and any submissions received will be considered at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationThis consultation is for interim decisions made in relation to applications to amend the Poisons Standard, following advice sought at the 3-4 November 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationThis consultation is for interim decisions made in relation to applications to amend the Poisons Standard, following advice sought at the 3-4 November 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS).
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationThe TGA is seeking feedback on the updated 'Listed medicines evidence guidelines - How to demonstrate efficacy of listed medicines'. Closing date: 1 April 2022
-
ConsultationConsultation seeking feedback on the repurposing of medicines to inform the development of options for Government consideration closed 1 April 2022
-
ConsultationThe TGA is seeking feedback on a proposed priority pathway for assessment of certain novel and life-saving biologicals. Closing date: 28 March 2022
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on options for the TGA's proposed fees and charges for the 2022-23 financial year. Closing date: 7 March 2022
-
ConsultationThe TGA is seeking feedback on whether certain international scientific guidelines should be adopted. Closing date: 20 February 2022
-
ConsultationThe TGA is seeking feedback from sponsors on improving their access to medicine adverse event data. Closing date 18 February 2022
-
ConsultationThe TGA is seeking feedback on a proposal to improve patient access to critical medicines in acute-care settings. Closing date: 7 February 2022
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 31 January 2022
-
ConsultationThe TGA is conducting a public consultation on potential options for the regulation of biologicals manufactured in Australia for export only (and not for supply in Australia). Closing date: 20 December 2021
-
ConsultationThe TGA sought feedback on a Discussion paper on potential changes to mandatory reporting of medical device adverse events.
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23 June 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23 June 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).